Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.

Freedman BI, Skorecki K.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):2006-13. doi: 10.2215/CJN.01330214. Epub 2014 Jun 5. Review.

2.

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA.

J Am Soc Nephrol. 2011 Nov;22(11):2129-37. doi: 10.1681/ASN.2011040388. Epub 2011 Oct 13.

3.

APOL1 variants associate with increased risk of CKD among African Americans.

Foster MC, Coresh J, Fornage M, Astor BC, Grams M, Franceschini N, Boerwinkle E, Parekh RS, Kao WH.

J Am Soc Nephrol. 2013 Sep;24(9):1484-91. doi: 10.1681/ASN.2013010113. Epub 2013 Jun 13.

4.

Apolipoprotein l1 and the genetic basis for racial disparity in chronic kidney disease.

Quaggin SE, George AL Jr.

J Am Soc Nephrol. 2011 Nov;22(11):1955-8. doi: 10.1681/ASN.2011090932. Epub 2011 Oct 13. No abstract available.

5.

APOL1 and nephropathy progression in populations of African ancestry.

Freedman BI.

Semin Nephrol. 2013 Sep;33(5):425-32. doi: 10.1016/j.semnephrol.2013.07.004. Review.

6.

APOL1 kidney risk alleles: population genetics and disease associations.

Limou S, Nelson GW, Kopp JB, Winkler CA.

Adv Chronic Kidney Dis. 2014 Sep;21(5):426-33. doi: 10.1053/j.ackd.2014.06.005. Review.

7.

Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.

Hawkins GA, Friedman DJ, Lu L, McWilliams DR, Chou JW, Sajuthi S, Divers J, Parekh RS, Li M, Genovese G, Pollack MR, Hicks PJ, Bowden DW, Ma L, Freedman BI, Langefeld CD.

Am J Nephrol. 2015;42(2):99-106. doi: 10.1159/000439448. Epub 2015 Sep 8.

8.

Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.

Anyaegbu EI, Shaw AS, Hruska KA, Jain S.

Pediatr Nephrol. 2015 Jun;30(6):983-9. doi: 10.1007/s00467-014-3031-0. Epub 2014 Dec 23.

9.

APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.

Papeta N, Kiryluk K, Patel A, Sterken R, Kacak N, Snyder HJ, Imus PH, Mhatre AN, Lawani AK, Julian BA, Wyatt RJ, Novak J, Wyatt CM, Ross MJ, Winston JA, Klotman ME, Cohen DJ, Appel GB, D'Agati VD, Klotman PE, Gharavi AG.

J Am Soc Nephrol. 2011 Nov;22(11):1991-6. doi: 10.1681/ASN.2011040434. Epub 2011 Oct 13.

10.

Effect of Genetic African Ancestry on eGFR and Kidney Disease.

Udler MS, Nadkarni GN, Belbin G, Lotay V, Wyatt C, Gottesman O, Bottinger EP, Kenny EE, Peter I.

J Am Soc Nephrol. 2015 Jul;26(7):1682-92. doi: 10.1681/ASN.2014050474. Epub 2014 Oct 27.

11.

Sequencing rare and common APOL1 coding variants to determine kidney disease risk.

Limou S, Nelson GW, Lecordier L, An P, O'hUigin CS, David VA, Binns-Roemer EA, Guiblet WM, Oleksyk TK, Pays E, Kopp JB, Winkler CA.

Kidney Int. 2015 Oct;88(4):754-63. doi: 10.1038/ki.2015.151. Epub 2015 May 20.

12.

Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.

Chen TK, Choi MJ, Kao WH, Astor BC, Scialla JJ, Appel LJ, Li L, Lipkowitz MS, Wolf M, Parekh RS, Winkler CA, Estrella MM, Crews DC.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2128-35. doi: 10.2215/CJN.05220515. Epub 2015 Oct 1.

13.

The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.

Freedman BI, Kopp JB, Langefeld CD, Genovese G, Friedman DJ, Nelson GW, Winkler CA, Bowden DW, Pollak MR.

J Am Soc Nephrol. 2010 Sep;21(9):1422-6. doi: 10.1681/ASN.2010070730. Epub 2010 Aug 5. Review.

14.

Rethinking hypertensive kidney disease: arterionephrosclerosis as a genetic, metabolic, and inflammatory disorder.

Kopp JB.

Curr Opin Nephrol Hypertens. 2013 May;22(3):266-72. doi: 10.1097/MNH.0b013e3283600f8c. Review.

15.

APOL1 and kidney disease.

Pollak MR, Genovese G, Friedman DJ.

Curr Opin Nephrol Hypertens. 2012 Mar;21(2):179-82. doi: 10.1097/MNH.0b013e32835012ab. Review.

PMID:
22257798
16.

Is it variants in the apolipoprotein l1 gene, or blood pressure control, that predicts progression of nondiabetic hypertensive nephropathy in African Americans?

Cohen DL, Townsend RR.

J Clin Hypertens (Greenwich). 2013 Jul;15(7):445-6. doi: 10.1111/jch.12126. Epub 2013 May 17. No abstract available.

17.

Apolipoprotein L1-associated nephropathy and the future of renal diagnostics.

Larsen CP, Freedman BI.

J Am Soc Nephrol. 2015 Jun;26(6):1232-5. doi: 10.1681/ASN.2014101052. Epub 2015 Jan 8. No abstract available.

18.

Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.

Atta MG, Estrella MM, Skorecki KL, Kopp JB, Winkler CA, Wasser WG, Shemer R, Racusen LC, Kuperman M, Foy MC, Lucas GM, Fine DM.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):262-70. doi: 10.2215/CJN.07490715. Epub 2015 Dec 14.

19.

APOL1 localization in normal kidney and nondiabetic kidney disease.

Madhavan SM, O'Toole JF, Konieczkowski M, Ganesan S, Bruggeman LA, Sedor JR.

J Am Soc Nephrol. 2011 Nov;22(11):2119-28. doi: 10.1681/ASN.2011010069. Epub 2011 Oct 13.

20.

Target organ damage in African American hypertension: role of APOL1.

Freedman BI, Murea M.

Curr Hypertens Rep. 2012 Feb;14(1):21-8. doi: 10.1007/s11906-011-0237-4. Review.

Supplemental Content

Support Center